Lianhe Chemical Technology Co.,Ltd.

SZSE:002250 Stock Report

Market Cap: CN¥5.4b

Lianhe Chemical TechnologyLtd Balance Sheet Health

Financial Health criteria checks 3/6

Lianhe Chemical TechnologyLtd has a total shareholder equity of CN¥6.8B and total debt of CN¥4.3B, which brings its debt-to-equity ratio to 62.9%. Its total assets and total liabilities are CN¥13.6B and CN¥6.9B respectively.

Key information

62.9%

Debt to equity ratio

CN¥4.27b

Debt

Interest coverage ration/a
CashCN¥1.40b
EquityCN¥6.78b
Total liabilitiesCN¥6.87b
Total assetsCN¥13.65b

Recent financial health updates

Recent updates

Little Excitement Around Lianhe Chemical Technology Co.,Ltd.'s (SZSE:002250) Revenues

Oct 24
Little Excitement Around Lianhe Chemical Technology Co.,Ltd.'s (SZSE:002250) Revenues

Is Lianhe Chemical TechnologyLtd (SZSE:002250) Using Debt In A Risky Way?

Sep 25
Is Lianhe Chemical TechnologyLtd (SZSE:002250) Using Debt In A Risky Way?

Lianhe Chemical TechnologyLtd's (SZSE:002250) Dividend Will Be Reduced To CN¥0.02

Jul 12
Lianhe Chemical TechnologyLtd's (SZSE:002250) Dividend Will Be Reduced To CN¥0.02

Why Investors Shouldn't Be Surprised By Lianhe Chemical Technology Co.,Ltd.'s (SZSE:002250) Low P/S

Jun 07
Why Investors Shouldn't Be Surprised By Lianhe Chemical Technology Co.,Ltd.'s (SZSE:002250) Low P/S

Returns Are Gaining Momentum At Lianhe Chemical TechnologyLtd (SZSE:002250)

Feb 28
Returns Are Gaining Momentum At Lianhe Chemical TechnologyLtd (SZSE:002250)

Financial Position Analysis

Short Term Liabilities: 002250's short term assets (CN¥5.2B) exceed its short term liabilities (CN¥3.7B).

Long Term Liabilities: 002250's short term assets (CN¥5.2B) exceed its long term liabilities (CN¥3.1B).


Debt to Equity History and Analysis

Debt Level: 002250's net debt to equity ratio (42.3%) is considered high.

Reducing Debt: 002250's debt to equity ratio has increased from 27.4% to 62.9% over the past 5 years.

Debt Coverage: 002250's debt is well covered by operating cash flow (26.9%).

Interest Coverage: Insufficient data to determine if 002250's interest payments on its debt are well covered by EBIT.


Balance Sheet


Discover healthy companies